Anti-MMP14抗体(ab3644)

Thank you for confirming these details and for your cooperation. The details provided enable us to closely monitor the quality of our products.
I am sorry this product did not perform as stated on the datasheet and for the inconvenience this has caused. As requested, I have issued a free of charge replacement with the order number xxx with ab51074.
To check the status of the order please contact our Customer Service team and reference this number.
Please note that this free of charge replacement vial is also covered by our Abpromise guarantee. Should you still be experiencing difficulties, or if you have any further questions, please do not hesitate to let us know.
I wish you the best of luck with your research.

Following-up my message from Friday, I did receive more information regarding ab3644: the immunogen is a 12 amino acid peptide found between amino acids 100-200 of human MPP-14. Since the pro-peptide is aa 1-111, and the antibody recognizes the active as well as latent forms of the protein, we can narrow this range further to aa 112-200. I hope this helps. For ab16267, I am afraid there is no more information available.

Thank you for your enquiry. I appreciate your continued patience in this matter. I have received some feedback from some of the sources of the antibodies that you are enquiring about; ab7033 - To follow on with the comments that I have made the source of mouse monoclonal [MMP2/2C1] to MMP2 (ab7033) was also concerned with regards the approach that you have used for your sample preparation. I appreciate that you have been using an NP40 buffer extraction. However, this is an approach designed for a cytoplasmic preparation of cell culture cells. I would like to follow up my previous email by recommending that you perform a loading control experiment using an antibody that targets a "housekeeping protein" for example GAPDH or beta actin. This can be performed under the conditions best recognized by the antibody you are using; most likely denaturing, reduced. This will enable you to fully determine the integrity of your protein with respect to its protein composition. My biggest concern with the blot images that you have provided me with are the band doublet that you have been detecting either side of the 37KDa marker as this is present in the majority of your blot images. The source of ab6586 - Collagen IV antibody (ab6586) makes a similar suggestion although Collagens should in fact be electrophoresed as you have been using non-denaturing, non-reduced conditions. However, it is important that the integrity of your samples are confirmed. I am still awaiting further information and am in the process of requesting blot images for the antibodies that you have enquired about. I appreciate your continued patience. I hope this information helps, please do not hesitate to contact us if you need any more advice or information.

Thank you for your enquiry. Once again I am sorry to hear of the difficulties that you have experienced using these antibodies. I have had a look through the information that you have provided in conjunction with the blot images and I have a few comments. Firstly I am concerned about the sample preparation that has been performed. Many of the extraneous bands that have been detected are significantly lower than I would expect. Curiously many are also doublets at approximately 25KDa and 37KDa. My suspicion would be non-specific labeling possibly due to protein degradation. You have highlighted that the samples were prepared as recommended by Abcam. Please can you detail exactly how this was performed as we make many recommendations for sample preparation. My concern with respect to the sample preparation is that many of the proteins that your are targeting are secreted proteins and therefore require delicate sample preparation. Can you tell me whether the skeletal muscle samples were postmortum, biopsies, surgical specimens etc. I would also appreciate details of the gel conditions that you are using. Similar to my previous response with respect to ab2500 I would appreciate it if you could provide me with details of the gel conditions. I would like to know whether these pre-cast gels are non-denaturing in addition to non-reduced. I would also like details of how the samples are prepared immediately prior to loading on the gel. Can you also provide me with details of the primary and secondary antibody dilutions that have been attempted for each of the samples. Given the non-specific reactivity that you have observed I am also interested whether any no-antibody control experiments have been performed to determine whether the extraneous bands are attricubatble to this reactivity. I additionally have a few comments with respect to individual antibodies that you have been applying: In the experiments that have been performed using ab1828, the secondary that has been employed is ab6721. This is an antibody that is specific for use by IHC and has not been tested for use in western blotting. We have received some excellent feedback as to the application of ab3644 through our Abreviews system. I would like to highlight the importance of a a suitable positive control. For MT1-MMP/MMP14 we recommend the use of placental or breast/lung tissue. For Collagen IV we recommend the use of human epidermal keratinocytes. I look forward to your comments on these matters.

Thank you for your enquiry. I am sorry to hear that you have been having difficulties with these antibodies. The results that you have been obtaining are certainly troubling. What concerns me the most are the two bands that you are consistently detecting at approximately 25 and 37KDa. You are consistently detecing cross reacting bands and never detecting the endogenous target. Whilst some of the antibodies that you detail have not been tested using rat samples; potentially explaining the absence of reactivity with the endogenous band the presence of the two bands at the aforementioned molecular weight accross many of your samples seems to suggest problems with the secondary antibody. Especially in view of the fact that you have changed this antibody and are in fact using three independent secondary antibodies: Goat polyclonal to Rabbit IgG H&L (HRP) (ab6721) Goat polyclonal to Rabbit IgG + Mouse IgG & IgM - prediluted (HRP polymer) (ab2891) Rabbit polyclonal to Goat IgG H&L (HRP) (ab6741) I would appreciate it if you could provide me with protocol details of the approach that you are using so that I can better determine potential reasons for these reacting bands. We have not observed such reactivity with any of the antibodies you list. I am particularly interested in the generic protocol that you have been applying. To provide me with these details please click on the link below and complete our on line technical questionaire. If you have modified the protocol for any of the antibodies at any point please mention this. I am also very interested in the method of sample preparation and the control antibody (loading control) that you have used. https://www.abcam.com/index.html?section=western&pageconfig=technical&intAbID=2500&mode=questionaire I look forward to hearing from you.

ab10800 -- Mouse monoclonal [HAS-3] to Integrin alpha 2 is provided at a concentration of 1mg/ml (this information was previosuly missing from the datasheet but has been added now). You do not mention which application the researcher plans to use the product, but knowing the concentration should now enable them to determine a starting dilution. There are also references on the datasheet that specifically feature the use of this antibody so please ask them to check here for further information. Positive controls: ab3644 -- Rabbit polyclonal to MMP14 Suitable tissue control sections for Immunohistochemistry: Placenta. Note the antibody cross reacts with human. This information is found on the positive control and cross reactivity sections of the datasheet. ab13018 -- Rabbit polyclonal to IL8 Receptor alpha There are beautiful IHC images on the datasheet showing staining of human skin, eccrine sweat glands. ab7747 -- Rabbit polyclonal to IL8 Shown to cross reacts with Human, Cynomolgus Monkey and Rhesus monkey. Product specific reference included on the datasheet is Fujii A et al. Differential expression of chemokines, chemokine receptors, cytokines and cytokine receptors in diffuse large B cell malignant lymphoma. Int J Oncol 24:529-38 (2004). PubMed: 14767537.